(GMT-05:00) Eastern Time (US & Canada)
45 minutes
In 2021, Massachusetts biotech companies received $13.66 billion in venture capital funding. Combined with a successful IPO market in past years, our industry has the capital on-hand for significant growth. At the same time, companies are facing on-going hiring challenges at all levels but especially for experienced talent. This panel of experts from industry and academia will explore what Massachusetts needs to do both short- and longer-term to address the workforce gap so we can continue as the State of Possible for industry and for patients.
In 2021, Massachusetts biotech companies received $13.66 billion in venture capital funding. Combined with a successful IPO market in past years, our industry has the capital on-hand for significant growth. At the same time, companies are facing on-going hiring challenges at all levels but especially for experienced talent. This panel of experts from industry and academia will explore what Massachusetts needs to do both short- and longer-term to address the workforce gap so we can continue as the State of Possible for industry and for patients.

Speakers

Julie Chen Ph.D. - Professor and Vice Chancellor for Research & Economic Development, UMass Lowell
Kendalle Burlin O’Connell - President & Chief Operating Officer, MassBio
Kenn Turner - President and CEO, Massachusetts Life Sciences Center
Luis G. Pedraja, Ph.D. - President, Quinsigamond Community College
Susan O'Connor - Chief Human Resources Officer, Beam Therapeutics
Tracks
Name Audience
Conference Wide